Credit Suisse’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-26
| Closed | – | – | 4413 |
|
|
2022
Q2 | $0 | Buy |
+26
| New | – | ﹤0.01% | 4476 |
|
|
2021
Q1 | – | Sell |
-15,226
| Closed | -$96K | – | 3620 |
|
|
2020
Q4 | $96K | Buy |
+15,226
| New | +$96K | ﹤0.01% | 3330 |
|
|
2019
Q2 | – | Sell |
-17,820
| Closed | -$95K | – | 3519 |
|
|
2019
Q1 | $95K | Buy |
17,820
+4,979
| +39% | +$26.5K | ﹤0.01% | 3258 |
|
|
2018
Q4 | $66K | Buy |
12,841
+2,008
| +19% | +$10.3K | ﹤0.01% | 3250 |
|
|
2018
Q3 | $106K | Sell |
10,833
-17,978
| -62% | -$176K | ﹤0.01% | 3239 |
|
|
2018
Q2 | $294K | Sell |
28,811
-1,102
| -4% | -$11.2K | ﹤0.01% | 3180 |
|
|
2018
Q1 | $389K | Buy |
29,913
+840
| +3% | +$10.9K | ﹤0.01% | 3056 |
|
|
2017
Q4 | $520K | Sell |
29,073
-9,019
| -24% | -$161K | ﹤0.01% | 2936 |
|
|
2017
Q3 | $956K | Buy |
38,092
+23,387
| +159% | +$587K | ﹤0.01% | 2683 |
|
|
2017
Q2 | $354K | Sell |
14,705
-3,405
| -19% | -$82K | ﹤0.01% | 2988 |
|
|
2017
Q1 | $349K | Buy |
18,110
+4,853
| +37% | +$93.5K | ﹤0.01% | 3103 |
|
|
2016
Q4 | $204K | Sell |
13,257
-3,027
| -19% | -$46.6K | ﹤0.01% | 3447 |
|
|
2016
Q3 | $212K | Buy |
16,284
+5,649
| +53% | +$73.5K | ﹤0.01% | 3447 |
|
|
2016
Q2 | $148K | Buy |
+10,635
| New | +$148K | ﹤0.01% | 3664 |
|
|
2015
Q2 | – | Sell |
-28,825
| Closed | -$901K | – | 4301 |
|
|
2015
Q1 | $901K | Buy |
28,825
+14,094
| +96% | +$441K | ﹤0.01% | 2812 |
|
|
2014
Q4 | $568K | Buy |
+14,731
| New | +$568K | ﹤0.01% | 3254 |
|